Gov Paid Coin-Operated Hospitals Bonuses for Every COVID Patient Treated w/Emergency Authorized Meds (Remdesivir) and a 300% Upcharge for Patients put on ventilators, despite Knowing it Killed People

/

STORY AT-A-GLANCE

  • In late March 2020, the U.S. Congress passed the Coronavirus Aid, Relief and Economic Security (CARES) Act. Within this $2 trillion stimulus package, $100 billion was earmarked for hospitals and local health centers that treated COVID patients

  • Hospitals were reimbursed an extra 20% for each Medicare patient hospitalized with COVID, and the only criteria to receive that bonus was a COVID-positive PCR test

  • The federal COVID-19 Treatments Add-On Payment program also paid hospitals bonuses for every COVID-19 patient treated with emergency-authorized COVID medications (Remdesivir, convalescent plasma, Baricitinib, Molnupiravir and Nirmatrelvir)

  • Hospitals also received a 300% upcharge for COVID patients placed on ventilators, even after it became apparent that this was a death sentence. Somewhere between 50% and 86% of all ventilated COVID patients died, yet government never dropped the incentive to use ventilators. Why?

  • Throughout 2020, evidence mounted showing the PCR test is incredibly unreliable above 35 cycles, and health agencies instructed labs to use 40 to 45 cycles. In essence, we had an epidemic of false positives, and financial incentives then drove hospitals to mistreat and kill countless patients, many of whom may not even have had COVID

From [HERE PDF] As detailed in “How COVID Patients Died for Profit,” hospitals were financially incentivized to diagnose patients with COVID and treat them with protocols known to be lethal, in part to “protect” the staff from infection.

As if that weren’t bad enough, primary care providers across the U.S. were also bribed to coerce patients into getting the toxic COVID shot. The following document was posted to Twitter in mid-April 2023 by Rep. Thomas Massie, an award-winning scientist and Republican Congressman for Kentucky.1

“Ethically, shouldn’t doctors disclose when they’re profiting by recommending a drug or treatment — especially a drug or treatment for which there is no medical malpractice liability?” Massie said.2 [MORE PDF]